KKR Affiliate to Buy Integer in $5.7 Billion Cash Deal
Early HSR termination clears one closing hurdle as the medical-device CDMO heads to a virtual stockholder vote on October 21.
Integer Holdings Corporation (ITGR), a global medical device contract development and manufacturing organization, received early termination of the Hart-Scott-Rodino waiting period for its pending all-cash sale to an affiliate of investment funds managed by KKR.
The termination satisfies one of the conditions required for completion of the transaction, which remains subject to stockholder approval, other regulatory approvals, and customary closing conditions. Integer continues to expect the deal to close by the end of 2026.
As previously announced on August 3, 2026, the parties entered into a definitive merger agreement dated August 2, 2026, under which the KKR affiliate will acquire all outstanding shares of Integer for $127 a share in cash, a total enterprise value of approximately $5.7 billion.
The company will hold a virtual special meeting of stockholders on October 21, 2026, at 9:00 a.m. Central Time, to vote to adopt the merger agreement and approve related proposals. Stockholders of record as of the close of business on September 8, 2026, are entitled to vote. The board unanimously recommends that stockholders vote “FOR” the merger agreement and the other related proposals.
A definitive proxy statement was filed with the Securities and Exchange Commission on September 14, 2026.
Integer is one of the largest medical device CDMOs in the world, serving the cardio and vascular, neuromodulation, and cardiac rhythm management markets. Its brands include Greatbatch Medical and Lake Region Medical.
The merger is expected to close by the end of calendar year 2026, subject to the remaining conditions, including approvals under certain other applicable antitrust and foreign direct investment laws.